Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MIRA PHARMACEUTICALS, INC. | Director | Stock Options | 10K | Aug 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | General Counsel, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 2, 2023 | 0 | $0 | 3 | Aug 2, 2023 | Director |